Related Experiment Video
Updated: Jun 24, 2026
08:51
Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
Published on: March 1, 2013
A novel nonviral gene delivery system: multifunctional envelope-type nano device
Hiroto Hatakeyama1, Hidetaka Akita, Kentaro Kogure
1Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12 Nishi 6, Sapporo City, Hokkaido, 060-0812, Japan.
Advances in Biochemical Engineering/Biotechnology
|April 4, 2009
Summary
Researchers developed a novel nonviral gene delivery system called Programmed Packaging, creating multifunctional envelope-type nano devices (MENDs). These MENDs show high transfection activity and are effective for in vivo tumor targeting.
Area of Science:
- Biotechnology
- Nanomedicine
- Gene Therapy
Background:
- Nonviral gene delivery systems are crucial for therapeutic applications but often face challenges in efficiency and targeting.
- Adenoviral vectors are effective but have safety concerns, necessitating the development of safer alternatives.
- Existing nonviral systems require optimization to achieve comparable or superior transfection efficiencies.
Purpose of the Study:
- To introduce the Programmed Packaging concept for nonviral gene delivery.
- To develop and evaluate multifunctional envelope-type nano devices (MENDs) for enhanced gene transfection.
- To create an in vivo tumor-targeting MEND and a quantitative analysis system for gene delivery.
Main Methods:
- Development of multifunctional envelope-type nano devices (MENDs) based on the Programmed Packaging concept.
- Design of PEG/peptide/DOPE ternary conjugate (PPD)-MEND for tumor targeting, utilizing matrix metalloproteinase (MMP) sensitive PEG dissociation.
- Establishment of Confocal Image-assisted 3-dimensionally integrated quantification (CIDIQ) for quantitative gene delivery analysis.
Main Results:
- MENDs demonstrated high transfection activities in dividing cells, comparable to adenovirus.
- PPD-MEND showed effective in vivo tumor targeting and significant transfection activity.
- CIDIQ analysis identified rate-limiting steps in nonviral gene delivery by comparison with adenoviral vectors.
Conclusions:
- The Programmed Packaging concept enables the development of highly efficient nonviral gene delivery systems.
- MENDs, particularly PPD-MEND, offer a promising platform for targeted in vivo gene therapy.
- Quantitative analysis with CIDIQ provides critical insights for the rational design of future gene delivery systems.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.